Übersicht			Auf mobile öffnen

Lieferstatus:	Auf Bestellung (Lieferzeit unbekannt)
Veröffentlichung:	August 2013
Genre:	Naturwissensch., Medizin, Technik
	B / Biomedical and Life Sciences / Cancer Biology / Cancer Research / Cancer;Cancer Research;Factors;Modifiers;Transcriptional / Pharmacology / Pharmacology/Toxicology / Pharmakologie
ISBN:	9781461480389
EAN-Code:	9781461480389
Verlag:	Springer EN
Einband:	Gebunden
Sprache:	English
Serie:	Cancer Drug Discovery and Development
Dimensionen:	H 235 mm / B 155 mm / D 29 mm
Gewicht:	896 gr
Seiten:	439
Illustration:	XII, 439 p.
Zus. Info:	EUDR exemption - product or manufacturing materials placed on the market prior to 31.12.2025.
Bewertung:	Titel bewerten / Meinung schreiben

Inhalt:

This book presents the most up-to-date information in the area of targeted therapeutics with a particular focus on pathway-centered approaches and transcription by leading authorities in molecular cancer research. The goal is to cover several critical principles of cancer therapeutics, ranging from regulation of cancer associated genes by coregulators, cancer cell signaling, modifiers of epigenome functionality and specific protein domains, and emerging significance of splicing. The book is directed for basic and translational scientists, clinicians, clinical investigators, fellows, residents, graduate students, and educators in the areas of molecular therapeutics and cancer medicine, and medical sciences at-large. Readers will be able to grasp the overall importance of the pathway, associated pathobiology and clinical manifestation, and possible points of intervention with a goal to solidify new cancer therapeutic targets.